SV

Street Verdict

Analyst Scorecard

A record of what Marketsmith India Analysis said publicly, with the source. Not advice.

“Recommends buying Fortis Healthcare Ltd at ₹692 with a target price of ₹845 in three months and a stop loss at ₹625, based on strategic capacity expansion, robust financial performance, and a horizontal trendline breakout.”

Marketsmith India Analysis’s track record (trackable calls only): 322 graded calls · 95% CI 22–32%

Fortis Healthcare LtdBullishCalled 15 May 2025Graded 24 Jul 2025
Verdict:HIT

How this call is judged

A call is judged on closing prices only: a close at its target is a hit and a close at its stop is a miss. A call that states an entry starts at the first close that reaches it; if none does in the days allowed, it was never triggered, is not graded and counts toward no hit rate. No time frame is stated and the call gives both a target and a stop, so it is tracked until a close reaches one of them (rule H6): the target first is a hit, the stop first a miss, and until then it stays open.

Entry: ₹692, as stated.

Target ₹845, stop ₹625, as stated.

No time frame is stated, so it is tracked until a close reaches ₹845 or ₹625: there is no fixed window.

The target ₹845 was reached on a close before the stop ₹625. Hit.

The grader’s working: R3 TRADE_SETUP: entered ₹692 on 2025-05-16 (stated entry ₹692, LEVEL_CMP entry, filled); target ₹845 reached at close ₹846.55 on 2025-07-24. No time frame is stated and the call gives both a target and a stop, so it is tracked until a close reaches one of them (rule H6): the target first is a hit, the stop first a miss, and until then it stays open.

Tracking Fortis Healthcare Ltd since this call

1-year tracking window
Read the original articleSee Marketsmith India Analysis’s full track record